NCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
Shanghai Jiao Tong University School of Medicine
Barbara Ann Karmanos Cancer Institute
Icahn School of Medicine at Mount Sinai
Yale University
Southern Europe New Drug Organization